Finch Therapeutics is a pioneer in the microbiome therapeutics field, focusing on innovative microbiome assets with potential applications across various therapeutic areas. The company has a robust intellectual property estate and is developing therapeutics aimed at conditions such as recurrent C. difficile infection, ulcerative colitis, Crohn’s disease, and autism spectrum disorder.

Finch Therapeutics is a pioneer in the microbiome therapeutics field, focusing on innovative microbiome assets with potential applications across various therapeutic areas. The company has a robust intellectual property estate and is developing therapeutics aimed at conditions such as recurrent C. difficile infection, ulcerative colitis, Crohn’s disease, and autism spectrum disorder.